Bayer has a proven long‑term commitment to the haemophilia community. In addition to our rFVIII products, this includes providing tailored support for healthcare professionals, patients and carers.
This commitment is founded on 25 years’ experience in haemophilia. The knowledge and expertise gained over this period benefits both patients and healthcare professionals alike. By helping patients understand and control their condition, we can improve long‑term patient outcomes and joint health. Similarly, Bayer’s provision of educational materials and sponsored meetings ensure healthcare professionals specialising in haemophilia are kept up‑to‑date with the latest developments and discussions in the management of bleeding disorders.